LTA4H Inhibitors
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
Captopril exhibits unique characteristics as an LTA4H inhibitor, showcasing its ability to disrupt leukotriene biosynthesis. Its specific molecular interactions involve competitive binding to the enzyme's active site, which alters the kinetics of substrate conversion. The compound's structural features, including its thiol group, enhance nucleophilicity, promoting effective interactions with electrophilic centers. Additionally, its hydrophilic nature influences solubility and distribution within biological systems, impacting overall reactivity. | ||||||
SC 57461A | 423169-68-0 | sc-204266 sc-204266A | 5 mg 25 mg | $151.00 $577.00 | 1 | |
SC 57461A functions as a selective inhibitor of LTA4H, demonstrating distinct molecular interactions that modulate enzyme activity. Its unique structural configuration allows for specific non-covalent interactions with the enzyme, influencing the conformational dynamics and stability of the enzyme-substrate complex. The compound's hydrophobic regions enhance membrane permeability, while its electronic properties facilitate rapid reaction kinetics, contributing to its efficacy in altering leukotriene metabolism. | ||||||
LTA3 (Leukotriene A3 methyl ester) | 83851-38-1 | sc-200490 sc-200490A | 50 µg 1 mg | $167.00 $2000.00 | ||
LTA3 (Leukotriene A3 methyl ester) exhibits unique reactivity as an acid halide, engaging in nucleophilic acyl substitution reactions that highlight its electrophilic nature. Its structural features promote specific interactions with nucleophiles, leading to the formation of stable adducts. The compound's steric hindrance influences reaction rates, while its solubility characteristics enhance its distribution in biological systems, affecting its interaction with various biomolecules. | ||||||